GlassScriptPhysician profile
Hongchen Jia
NPI 1790796548
$405.70
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $70.06.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $40.21 | 2019 | |
| Genentech USA, INC. | $34.81 | 2019 | |
| Tersera Therapeutics LLC | $30.68 | 2019 | |
| Amgen INC. | $27.68 | 2019 | |
| Merck Sharp & Dohme LLC | $27.44 | 2019-2020 | |
| Abbvie INC. | $25.81 | 2019-2020 | |
| Bioptics, INC. | $24.47 | 2019 | |
| Seagen INC. | $24.17 | 2019 | |
| Puma Biotechnology, INC. | $19.96 | 2019 | |
| Janssen Biotech, INC. | $15.83 | 2020 | |
| Jazz Pharmaceuticals INC. | $15.06 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.05 | 2020 | |
| Octapharma USA, INC. | $12.48 | 2019 | |
| Agios Pharmaceuticals, INC. | $12.35 | 2019 | |
| Eisai INC. | $12.30 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $11.97 | 2019 | |
| Astellas Pharma US INC | $11.57 | 2019 | |
| Shire North American Group INC | $11.13 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.04 | 2019 | |
| Celgene Corporation | $10.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hongchen Jia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.